NASDAQ Biotechnology Index (NBI) Companies by Market Cap
The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.74 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$1.74 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 201 |
Altimmune Inc
NASDAQ:ALT |
% | $374.44 Million | Healthcare | Biotechnology | $2.99 | -1.97% |
| 202 |
Larimar Therapeutics Inc
NASDAQ:LRMR |
% | $373.98 Million | Healthcare | Biotechnology | $3.73 | -12.97% |
| 203 |
Vanda Pharmaceuticals Inc
NASDAQ:VNDA |
% | $354.65 Million | Healthcare | Biotechnology | $6.00 | -3.85% |
| 204 |
Atea Pharmaceuticals Inc
NASDAQ:AVIR |
% | $351.32 Million | Healthcare | Biotechnology | $4.74 | -5.01% |
| 205 |
Keros Therapeutics Inc
NASDAQ:KROS |
% | $338.17 Million | Healthcare | Biotechnology | $11.10 | -5.93% |
| 206 |
Lyell Immunopharma Inc
NASDAQ:LYEL |
% | $334.30 Million | Healthcare | Biotechnology | $14.33 | -4.53% |
| 207 |
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO |
% | $329.79 Million | Healthcare | Biotechnology | $4.65 | -3.63% |
| 208 |
Silence Therapeutics PLC
NASDAQ:SLN |
% | $326.86 Million | Healthcare | Biotechnology | $9.29 | +2.20% |
| 209 |
Amarin Corporation PLC
NASDAQ:AMRN |
% | $308.25 Million | Healthcare | Drug Manufacturers - General | $14.70 | -1.21% |
| 210 |
OmniAb Inc.
NASDAQ:OABI |
% | $305.89 Million | Healthcare | Biotechnology | $2.11 | -7.86% |
| 211 |
Scpharmaceuticals Inc
NASDAQ:SCPH |
% | $304.36 Million | Healthcare | Biotechnology | $5.67 | +0.00% |
| 212 |
Editas Medicine Inc
NASDAQ:EDIT |
% | $299.59 Million | Healthcare | Biotechnology | $3.16 | -3.07% |
| 213 |
Foghorn Therapeutics Inc
NASDAQ:FHTX |
% | $288.22 Million | Healthcare | Biotechnology | $5.44 | -8.57% |
| 214 |
Neumora Therapeutics, Inc.
NASDAQ:NMRA |
% | $271.90 Million | Healthcare | Biotechnology | $1.60 | -4.76% |
| 215 |
2Seventy Bio Inc
NASDAQ:TSVT |
% | $266.14 Million | Healthcare | Biotechnology | $5.00 | +0.00% |
| 216 |
SIGA Technologies Inc
NASDAQ:SIGA |
% | $258.92 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $3.61 | +0.56% |
| 217 |
Inozyme Pharma Inc
NASDAQ:INZY |
% | $258.25 Million | Healthcare | Biotechnology | $4.00 | +0.00% |
| 218 |
Entrada Therapeutics Inc
NASDAQ:TRDA |
% | $252.25 Million | Healthcare | Biotechnology | $6.60 | -4.62% |
| 219 |
AC Immune Ltd
NASDAQ:ACIU |
% | $249.35 Million | Healthcare | Biotechnology | $2.45 | +2.51% |
| 220 |
Third Harmonic Bio Inc.
NASDAQ:THRD |
% | $242.79 Million | Healthcare | Biotechnology | $5.38 | +0.00% |
| 221 |
ACELYRIN, INC. Common Stock
NASDAQ:SLRN |
% | $229.17 Million | Healthcare | Biotechnology | $2.27 | +0.00% |
| 222 |
MacroGenics Inc
NASDAQ:MGNX |
% | $218.65 Million | Healthcare | Biotechnology | $4.50 | +3.93% |
| 223 |
Anavex Life Sciences Corp
NASDAQ:AVXL |
% | $217.78 Million | Healthcare | Biotechnology | $2.35 | -6.00% |
| 224 |
Bicycle Therapeutics Ltd
NASDAQ:BCYC |
% | $217.20 Million | Healthcare | Biotechnology | $4.35 | -1.36% |
| 225 |
CARGO Therapeutics, Inc. Common Stock
NASDAQ:CRGX |
% | $216.19 Million | Healthcare | Biotechnology | $4.47 | +0.00% |
| 226 |
Alpha Teknova Inc
NASDAQ:TKNO |
% | $205.34 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $5.41 | +0.93% |
| 227 |
Nkarta Inc
NASDAQ:NKTX |
% | $199.61 Million | Healthcare | Biotechnology | $2.79 | -6.06% |
| 228 |
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT |
% | $190.72 Million | Healthcare | Biotechnology | $6.71 | -3.73% |
| 229 |
Atrium Therapeutics, Inc. Common Stock
NASDAQ:RNA |
% | $189.59 Million | Healthcare | Biotechnology | $12.22 | -1.93% |
| 230 |
Voyager Therapeutics Inc
NASDAQ:VYGR |
% | $180.14 Million | Healthcare | Biotechnology | $3.24 | -5.81% |
| 231 |
Cartesian Therapeutics Inc.
NASDAQ:RNAC |
% | $172.18 Million | Healthcare | Biotechnology | $8.63 | -8.77% |
| 232 |
Alector Inc
NASDAQ:ALEC |
% | $166.65 Million | Healthcare | Biotechnology | $1.51 | -6.21% |
| 233 |
LENZ Therapeutics Inc
NASDAQ:LENZ |
% | $163.98 Million | Healthcare | Biotechnology | $5.23 | -6.44% |
| 234 |
Humacyte Inc
NASDAQ:HUMA |
% | $153.46 Million | Healthcare | Biotechnology | $0.69 | -0.40% |
| 235 |
Mersana Therapeutics Inc
NASDAQ:MRSN |
% | $145.36 Million | Healthcare | Biotechnology | $29.08 | +0.14% |
| 236 |
Fate Therapeutics Inc
NASDAQ:FATE |
% | $131.50 Million | Healthcare | Biotechnology | $3.02 | -2.58% |
| 237 |
PepGen Ltd
NASDAQ:PEPG |
% | $121.74 Million | Healthcare | Biotechnology | $2.44 | +4.27% |
| 238 |
Codexis Inc
NASDAQ:CDXS |
% | $112.91 Million | Healthcare | Biotechnology | $2.25 | -7.41% |
| 239 |
Q32 Bio Inc
NASDAQ:QTTB |
% | $91.06 Million | Healthcare | Biotechnology | $21.38 | +90.72% |
| 240 |
Terns Pharmaceuticals Inc
NASDAQ:TERN |
% | $87.01 Million | Healthcare | Biotechnology | $0.80 | +0.00% |
| 241 |
Pyxis Oncology Inc
NASDAQ:PYXS |
% | $86.55 Million | Healthcare | Biotechnology | $2.44 | -8.61% |
| 242 |
Biomea Fusion Inc
NASDAQ:BMEA |
% | $86.04 Million | Healthcare | Biotechnology | $1.33 | +0.76% |
| 243 |
MaxCyte Inc
NASDAQ:MXCT |
% | $84.42 Million | Healthcare | Medical Devices | $1.38 | +3.76% |
| 244 |
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ:ARTV |
% | $82.80 Million | Healthcare | Biotechnology | $8.93 | -7.37% |
| 245 |
Sutro Biopharma
NASDAQ:STRO |
% | $79.09 Million | Healthcare | Biotechnology | $27.84 | -6.36% |
| 246 |
Pliant Therapeutics Inc
NASDAQ:PLRX |
% | $70.59 Million | Healthcare | Biotechnology | $1.14 | +1.79% |
| 247 |
Tscan Therapeutics Inc
NASDAQ:TCRX |
% | $62.91 Million | Healthcare | Biotechnology | $1.03 | -5.50% |
| 248 |
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV |
% | $52.70 Million | Healthcare | Biotechnology | $1.98 | +1.02% |
| 249 |
IGM Biosciences Inc
NASDAQ:IGMS |
% | $46.47 Million | Healthcare | Biotechnology | $1.27 | -2.31% |
| 250 |
Tevogen Bio Holdings Inc.
NASDAQ:TVGN |
% | $21.10 Million | Healthcare | Biotechnology | $5.00 | -1.19% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices